Building on Organon’s prior FP2030 commitment, the company announces $30 million in new funding to fuel global action and community-driven solutions needed by the 121 million women and girls who experience unplanned pregnancies each year.
Nelarabine Injection ensures access to a lifesaving treatment, particularly for children, that historically has been in shortage.
Standard Media Index's latest data suggests that 2022 may have been a tipping point in the transition to digital pharma advertising.
Pharmaceutical companies are increasingly using radio advertising, both traditional and digital.
Survey: HCPs Rank Corporate Reputation as Leading Factor After Drug Efficacy and Safety
Enterprise generative AI focused on life sciences to bring life-saving drugs to market faster.